08-31-2023
KRW/share | |
Price | 64,700.00 |
Dividend | 122.93 |
Earnings | 922.97 |
Cash-flow | 1,258.75 |
Book value | 12,940.00 |
Equity | 12,999.58 |
Celltrion Healthcare is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Celltrion Healthcare is a company from Korea, and his stocks are publicly traded.
Celltrion Healthcare stock dividend
Celltrion Healthcare paid a total dividend of 19,792 million KRW last year, for a market value of 10,416,700 millions (Market Cap 6,349,848 millions). Celltrion Healthcare dividend per share is 122.93 KRW, and his stock market price 64,700.00 KRW.
According to the chart below, where dividend yield is displayed, Celltrion Healthcare has a dividend yield of 0.19%, lower than the amount offered by both the market average and companies from Korea. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Celltrion Healthcare stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best Korea dividend stocks list.
Celltrion Healthcare Dividend Payout
About the ability of Celltrion Healthcare to maintain his current dividend of KRW 122.93 per share, an amount that accounts for 0.19%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Celltrion Healthcare payout on ernings is currently 13.32%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that Celltrion Healthcarecan maintain his current dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Celltrion Healthcare is KRW 1,258.75 per share, which is higher than the dividend per share paid by the company of KRW 122.93, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Celltrion Healthcare, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Celltrion Healthcare Dividend History
Below you will find a table with the historical evolution of Celltrion Healthcare's dividend stock, both in percentage and in KRW, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | KRW | Paypout | Shares* |
Present | 0.19% | 122.93 | 13.32% | 161 |
2022 | 0.22% | 127.60 | 13.35% | 161 |
2021 | 0.32% | 256.64 | 16.67% | 156 |
2020 | 0.00% | 0.00 | 0.00% | 152 |
2019 | 0.00% | 0.00 | 0.00% | 149 |
2018 | 0.00% | 0.00 | 0.00% | 143 |
2017 | 0.00% | 0.00 | 0.00% | 139 |
*In millions
Celltrion Healthcare Stock performance
Finally, last moth Celltrion Healthcare showed a return of -1.70% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -6.70% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.